Document:

Exhibit
4.4

 

UNLESS
PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY MUST NOT TRADE THE SECURITY BEFORE THE DATE THAT IS 4 MONTHS
AND A DAY AFTER THE LATER OF (I) MAY 2, 2019, AND (II) THE DATE THE CORPORATION
BECAME A REPORTING ISSUER IN ANY PROVINCE OR TERRITORY OF CANADA.

 

THE
WARRANT EVIDENCED HEREBY IS EXERCISABLE ON OR BEFORE 5:00 PM (VANCOUVER TIME) ON MAY 2,
2024, SUBJECT TO ACCELERATION OF THE EXPIRY TIME AND THE EXPIRY DATE AS SET FORTH HEREIN, AFTER WHICH TIME THE WARRANTS
EVIDENCED HEREBY SHALL BE DEEMED TO BE VOID AND OF NO FURTHER FORCE OR EFFECT.

 

WARRANTS
TO PURCHASE 

COMMON
SHARES OF CANIVATE GROWING SYSTEMS LTD.

 

	Warrant
                                         Certificate Number:

         

        «Warrant_Cert_No»
	Number
                                         of Warrants:

         

        «No_of_Warrants»

 

THIS
IS TO CERTIFY THAT for value received «Registration_Name», «Registration_Address» (the “Warrantholder”)
has the right to purchase in respect of each whole warrant (collectively the “Warrants”) represented by this
certificate or by a replacement certificate (in either case this “Warrant Certificate”), at any time up to
5:00 PM Vancouver time (the “Expiry Time”), on May 2, 2024 (the “Expiry Date”), subject
to acceleration as provided in Section 3 of Schedule “A” to this Warrant Certificate one fully paid and non-assessable
common share (collectively the “Common Shares” and which term shall include any shares or other securities
to be issued in addition thereto or in substitution or replacement therefor as provided herein) of Canivate Growing Systems Ltd.
(the “Corporation”), a corporation incorporated under the British Columbia Business Corporations Act,
as constituted on the date hereof at a purchase price (the purchase price in effect from time to time being called the “Exercise
Price”) of $2.00 (Cdn) per Common Share. The number of Common Shares which the Warrantholder is entitled to acquire
upon exercise of the Warrants and the Exercise Price are subject to adjustment as hereinafter provided.

 

The
Corporation agrees that the Common Shares purchased pursuant to the exercise of the Warrants shall be and be deemed to be issued
to the Warrantholder as of the close of business on the date on which this Warrant Certificate shall have been surrendered and
payment made for such Common Shares as aforesaid.

 

Nothing
contained herein shall confer any right upon the Warrantholder to subscribe for or purchase any Common Shares at any time after
the Expiry Time on the Expiry Date and from and after the Expiry Time on the Expiry Date the Warrants (unless expiry is accelerated
under Section 3 of Schedule “A”) and all rights under this Warrant Certificate shall be void and of no value.

 

This
Warrant Certificate is issued upon the terms and conditions as are set out in Schedule “A” hereto, which terms, conditions
and provisions are attached hereto and are incorporated herein and form a part hereof. Unless the context otherwise requires capitalized
expressions herein shall have the meanings provided for in Schedule “A” hereto.

 

    	 

    2

    

 

IN
WITNESS WHEREOF the Corporation has caused this Warrant Certificate to be executed by its duly authorized officers this 2nd
day of May, 2019.

 

	 	CANIVATE
    GROWING SYSTEMS LTD.
	 	 	 
	 	Per:	 
	 	 	Authorized
    Signatory

 

    	 

    1

    

 

SCHEDULE
“A”

TERMS
AND CONDITIONS

ATTACHED TO WARRANTS ISSUED BY

CANIVATE GROWING SYSTEMS LTD.

(the “Corporation”)

 

Each
Warrant is subject to these Terms and Conditions as they were at the date of issue of the Warrant.

 

Terms
used but not otherwise defined herein have the meaning ascribed thereto on the face page of the Warrant Certificate.

 

	1.	Definitions:
    In this Warrant Certificate, unless there is something in the subject matter or context inconsistent therewith, the following
    expressions shall have the following meanings namely:

 

	 	a)	“Accelerated
    Expiry Date” has the meaning set forth in Section 3 of this Warrant Certificate;
	 	 	 
	 	b)	 “Acceleration
    Notice” has the meaning set forth in Section 3 of this Warrant Certificate;
	 	 	 
	 	c)	“Adjustment
    Period” means the period commencing on the date of issue of the Warrants and ending at the Expiry Time on the Expiry
    Date;
	 	 	 
	 	d)	“Current
    Market Price” of the Common Shares at any date means the price per share equal to the weighted average price at
    which the Common Shares have traded on the Canadian Securities Exchange or, if the Common Shares are not then listed on the
    Canadian Securities Exchange, on such other Canadian stock exchange as may be selected by the directors of the Corporation
    for such purpose or, if the Common Shares are not then listed on any Canadian stock exchange, in the over-the-counter market,
    during the period of any 20 consecutive trading days ending not more than five business days before such date; provided that
    the weighted average price shall be determined by dividing the aggregate sale price of all Common Shares sold on the said
    exchange or market, as the case may be, during such 20 consecutive trading days by the total number of Common Shares so sold;
    and provided further that if the Common Shares are not then listed on any Canadian stock exchange or traded in the over-the-counter
    market, then the Current Market Price shall be determined by a firm of independent chartered accountants selected by the directors
    of the Corporation;
	 	 	 
	 	e)	“director”
    means a director of the Corporation for the time being and, unless otherwise specified herein, a reference to action “by
    the directors” means action by the directors of the Corporation as a board or, whenever empowered, action by any committee
    of the directors of the Corporation;
	 	 	 
	 	f)	“trading
    day” with respect to a stock exchange or over-the-counter market means a day on which such stock exchange or market
    is open for business;
	 	 	 
	 	g)	“Regulation
    S” means Regulation S promulgated under the U.S. Securities Act;

 

    	 

    2

    

 

	 	h)	“United
    States” has the meaning prescribed in Regulation S;
	 	 	 
	 	i)	“U.S.
    Person” has the meaning prescribed in Regulation S; and
	 	 	 
	 	j)	“U.S.
    Securities Act” means the United States Securities Act of 1933, as amended.

 

In
addition, words importing the singular number include the plural and vice versa, and words importing the masculine gender include
feminine and neuter genders.

 

	2.	Exercise:
    In the event that the Warrantholder desires to exercise the right to purchase Common Shares conferred hereby, the Warrantholder
    shall:

 

	 	a)	complete
    to the extent possible in the manner indicated and execute a subscription form in the form attached as Schedule “B”
    to this Warrant Certificate if the Warrantholder is not a U.S. Person, resident in the United States or otherwise not subject
    to the securities laws of the United States, or Schedule “C” to this Warrant Certificate if the Warrantholder
    is a U.S. Person, resident in the United States or otherwise subject to the securities laws of the United States,
	 	 	 
	 	b)	surrender
    this Warrant Certificate to the Corporation in accordance with section 13 hereof, and
	 	 	 
	 	c)	pay
    the amount payable on the exercise of such Warrants in respect of the Common Shares subscribed for by certified cheque, bank
    draft or money order in lawful money of Canada payable to the Corporation or by transmitting same day funds in lawful money
    of Canada by wire to such account as the Corporation shall direct the Warrantholder.

 

Upon
such surrender and payment as aforesaid, the Warrantholder shall be deemed for all purposes to be the holder of record of the
number of Common Shares to be so issued and the Warrantholder shall be entitled to delivery of a certificate or certificates representing
such Common Shares and the Corporation shall cause such certificate or certificates to be delivered to the Warrantholder at the
address specified in the subscription form within three business days after such surrender and payment as aforesaid. No fractional
Common Shares will be issuable upon any exercise of this Warrant and the Warrantholder will not be entitled to any cash payment
or compensation in lieu of a fractional Common Share.

 

	3.	Acceleration
    of Expiry Time: In the event that the Common Shares trade for a minimum of $3.00 per Common Share for any ten (10) consecutive
    trading days at any time prior to the Expiry Date, the Company may accelerate the Expiry Date for the Warrants as follows:

 

	 	a)	the
    Company will be entitled to give notice of acceleration (an “Acceleration Notice”) to the Warrantholder
    in order to accelerate the Expiry Date;
	 	 	 
	 	b)	upon
    delivery of an Acceleration Notice to a Warrantholder, the Expiry Date will be accelerated to 5:00pm on the date that is 30
    calendar days from the date of delivery of the Acceleration Notice to the Warrantholder (the “Accelerated Expiry
    Date”);

 

    	 

    3

    

 

	 	c)	the
    Warrantholder will be entitled to exercise the Warrants up to the Expiry Time on the Accelerated Expiry Date; and
	 	 	 
	 	d)	if
    the Warrantholder does not exercise the Warrants by the Expiry Time on the Accelerated Expiry Date, the Warrant and the rights
    provided under this Warrant Certificate will terminate.

 

	4.	Partial
    Exercise: The Warrantholder may from time to time subscribe for and purchase any lesser number of Common Shares than the
    number of Common Shares expressed in this Warrant Certificate. In the event that the Warrantholder subscribes for and purchases
    any such lesser number of Common Shares prior to the Expiry Time on the Expiry Date, the Warrantholder shall be entitled to
    receive a replacement certificate representing the unexercised balance of the Warrants.
	 	 
	5.	Not
    a Shareholder: The holding of the Warrants shall not constitute the Warrantholder a shareholder of the Corporation nor
    entitle the Warrantholder to any right or interest in respect thereof except as expressly provided in this Warrant Certificate.
	 	 
	6.	Resale
    Restrictions and Legends on Common Shares:
	 	 
	 	The
    Common Shares received by the Warrantholder upon the exercise of the Warrants may be subject to a hold period as determined
    by the Securities Act (British Columbia), the rules and policies of the Canadian Securities Exchange (if the Common
    Shares are traded on the Canadian Securities Exchange at that time) or any other stock exchange on which the Common Shares
    are listed and/or other applicable securities laws.

 

Canadian
Legends

 

Any
certificate representing Common Shares issued upon the exercise of this Warrant prior to the date which is four months and one
day after the date the Company becomes a “reporting issuer” in Canada will bear the following legends (or other legend
as required to comply with applicable securities laws):

 

“UNLESS
PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY MUST NOT TRADE THE SECURITY BEFORE THE DATE THAT IS 4 MONTHS
AND A DAY AFTER THE LATER OF (I) MAY 2, 2019, AND (II) THE DATE THE CORPORATION
BECAME A REPORTING ISSUER IN ANY PROVINCE OR TERRITORY OF CANADA.”

provided
that at any time subsequent to the date which is four months and one day after the date the Company became a “reporting
issuer” any certificate representing such Common Shares may be exchanged for a certificate bearing no such legends.

 

U.S.
Resale Restrictions and Legends

 

This
Warrant and the Common Shares to be issued upon its exercise have not been and will not be registered under the U.S. Securities
Act or the securities laws of any state of the United States. This Warrant may not be exercised in the United States, or by or
for the account or benefit of a U.S. Person or a person in the United States, unless (i) the Common Shares are registered under
the U.S. Securities Act and the applicable laws of any such state, or (ii) an exemption from such registration requirements is
available, and (iii) the Warrantholder has complied with the requirements set forth in the subscription form attached hereto as
Schedule “C”.

 

    	 

    4

    

 

Any
Common Shares issued upon exercise of this Warrant in the United States, or to or for the account or benefit of a U.S. person
or a person in the United States, will be “restricted securities”, as defined in Rule 144(a)(3) under the U.S. Securities
Act. The certificates representing such Common Shares, as well as all certificates issued in exchange or in substitution therefor,
until such time as is no longer required under the applicable requirements of the U.S. Securities Act, or applicable state securities
laws, will bear, on the face of such certificate, the following legends:

 

“THE
SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “U.S.
SECURITIES ACT”) OR THE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES. THE HOLDER HEREOF, BY PURCHASING SUCH SECURITIES,
AGREES FOR THE BENEFIT OF CANIVATE GROWING SYSTEMS LTD. (THE “CORPORATION”) THAT SUCH SECURITIES MAY BE OFFERED, SOLD
OR OTHERWISE TRANSFERRED ONLY (A) TO THE CORPORATION; (B) OUTSIDE THE UNITED STATES IN ACCORDANCE WITH RULE 904 OF REGULATION
S UNDER THE U.S. SECURITIES ACT; (C) WITHIN THE UNITED STATES IN ACCORDANCE WITH THE EXEMPTION FROM REGISTRATION UNDER THE U.S.
SECURITIES ACT PROVIDED BY RULES 144 THEREUNDER, IF AVAILABLE, AND IN COMPLIANCE WITH ANY APPLICABLE STATE SECURITIES LAWS; OR
(D) IN A TRANSACTION THAT DOES NOT REQUIRE REGISTRATION UNDER THE U.S. SECURITIES ACT AND ANY APPLICABLE STATE SECURITIES LAWS,
AND, IN THE CASE OF PARAGRAPH (C) OR (D), THE SELLER FURNISHES TO THE CORPORATION AN OPINION OF COUNSEL OF RECOGNIZED STANDING
IN FORM AND SUBSTANCE SATISFACTORY TO THE CORPORATION TO SUCH EFFECT.

 

THE
PRESENCE OF THIS LEGEND MAY IMPAIR THE ABILITY OF THE HOLDER HEREOF TO EFFECT “GOOD DELIVERY” OF THE SECURITIES REPRESENTED
HEREBY ON A CANADIAN STOCK EXCHANGE. A CERTIFICATE WITHOUT A LEGEND MAY BE OBTAINED FROM THE REGISTRAR AND TRANSFER AGENT OF THE
CORPORATION IN CONNECTION WITH A SALE OF THE SECURITIES REPRESENTED HEREBY AT A TIME WHEN THE CORPORATION IS A “FOREIGN
ISSUER” AS DEFINED IN REGULATION S UNDER THE U.S. SECURITIES ACT, UPON DELIVERY OF THIS CERTIFICATE, AN EXECUTED DECLARATION
AND, IF REQUESTED BY THE CORPORATION OR THE TRANSFER AGENT, AN OPINION OF COUNSEL OF RECOGNIZED STANDING, EACH IN FORM AND SUBSTANCE
SATISFACTORY TO THE CORPORATION AND ITS TRANSFER AGENT, TO THE EFFECT THAT SUCH SALE OF THE SECURITIES REPRESENTED HEREBY IS BEING
MADE IN COMPLIANCE WITH RULE 904 OF REGULATION S UNDER THE U.S. SECURITIES ACT.”

 

provided,
that if the Common Shares are being sold outside the United States in compliance with the requirements of Rule 904 of Regulation
S under the U.S. Securities Act at a time when the Corporation is a “foreign issuer”, as defined in Rule 902(e) of
Regulation S at the time of sale, the legends set forth above may be removed by providing a declaration to the Corporation and
its registrar and transfer agent, as set forth in Schedule “D” attached hereto (or in such other form as the Corporation
prescribe from time to time); and provided, further, that, if the Common Shares are being sold otherwise than in accordance with
Rule 904 of Regulation S and other than to the Corporation, the legends may be removed by delivery to the Corporation and its
registrar and transfer agent of an opinion of counsel, of recognized standing reasonably satisfactory to the Corporation, that
such legends are no longer required under applicable requirements of the U.S. Securities Act or state securities laws.

 

    	 

    5

    

 

	7.	Transfer:
    The Warrants are transferable subject to compliance with applicable laws, including the rules and policies of any securities
    regulatory authority having jurisdiction any and any stock exchange on which the Common Shares are listed or traded. The term
    “Warrantholder” shall be deemed to include any successor, transferee or assignee of the current or any future
    Warrantholder. The Warrants may be transferred by the Warrantholder by completing and delivering to the Corporation the transfer
    form attached hereto as Schedule “E”, together with any such additional documentation or legal opinions reasonably
    required by the Corporation to evidence compliance with applicable laws. The Corporation shall issue and deliver, as soon
    as practicable and in any event within three (3) business days of delivery of such documentation, a new Warrant Certificate
    registered in the name of such transferee or as the transferee may direct and shall take all other necessary actions to effect
    the transfer as directed, which warrant certificate shall be endorsed with such legends as required to ensure compliance with
    applicable laws.
	 	 
	8.	Covenants,
    Representations and Warranties: The Corporation hereby represents and warrants that it is authorized to create and issue
    the Warrants and covenants and agrees that it will cause the Common Shares from time to time subscribed for and purchased
    in the manner provided in this Warrant Certificate and the certificate or certificates representing such Common Shares to
    be issued and that, at all times prior to the Expiry Time on the Expiry Date, it will reserve and there will remain unissued
    a sufficient number of Common Shares to satisfy the right of purchase provided for in this Warrant Certificate. The Corporation
    hereby further covenants and agrees that it will at its expense expeditiously use its best efforts to obtain the listing of
    such Common Shares (subject to issue or notice of issue) on each stock exchange or over-the-counter market on which the Common
    Shares may be listed from time to time. All Common Shares which are issued upon the exercise of the right of purchase provided
    in this Warrant Certificate, upon payment therefor of the amount at which such Common Shares may be purchased pursuant to
    the provisions of this Warrant Certificate, shall be and be deemed to be fully paid and non-assessable shares and free from
    all taxes, liens and charges with respect to the issue thereof. The Corporation hereby represents and warrants that this Warrant
    Certificate is a valid and enforceable obligation of the Corporation, enforceable in accordance with the provisions of this
    Warrant Certificate.

 

    	 

    6

    

 

	9.	Adjustment
    Provisions:

 

	 	a)	Adjustments:
    The Exercise Price and the number of Common Shares issuable to the Warrantholder upon the exercise of the Warrants shall be
    subject to adjustment from time to time in the events and in the manner provided as follows:

 

	 	i.	If
    at any time during the Adjustment Period the Corporation shall:

 

	 	1)	fix
    a record date for the issue of, or issue, Common Shares to the holders of all or substantially all of the outstanding Common
    Shares by way of a stock dividend;

 

	 	2)	fix
    a record date for the distribution to, or make a distribution to, the holders of all or substantially all of the outstanding
    Common Shares payable in Common Shares or securities exchangeable for or convertible into Common Shares;
	 	 	 
	 	3)	subdivide,
    redivide or exchange the outstanding Common Shares into a greater number of Common Shares; or
	 	 	 
	 	4)	consolidate,
    combine or reduce the outstanding Common Shares into a lesser number of Common Shares,

 

(any
of such events in subclauses 9(a)(i)(1), 9(a)(i)(2), 9(a)(i)(3) and 9(a)(i)(4) above being herein called a “Common Share
Reorganization”), the Exercise Price shall be adjusted on the earlier of the record date on which holders of Common
Shares are determined for the purposes of the Common Share Reorganization and the effective date of the Common Share Reorganization
to the amount determined by multiplying the Exercise Price in effect immediately prior to such record date or effective date,
as the case may be, by a fraction:

 

	 	A.	the
    numerator of which shall be the number of Common Shares outstanding on such record date or effective date, as the case may
    be, before giving effect to such Common Share Reorganization; and
	 	 	 
	 	B.	the
    denominator of which shall be the number of Common Shares which will be outstanding immediately after giving effect to such
    Common Share Reorganization (including in the case of a distribution of securities exchangeable for or convertible into Common
    Shares the number of Common Shares that would have been outstanding had such securities been exchanged for or converted into
    Common Shares on such date).

 

    	 

    7

    

 

 

	 	 	To
    the extent that any adjustment in the Exercise Price occurs pursuant to this clause 9(a)(i) as a result of the fixing by the
    Corporation of a record date for the distribution of securities exchangeable for or convertible into Common Shares, the Exercise
    Price shall be readjusted immediately after the expiry of any relevant exchange or conversion right to the Exercise Price
    which would then be in effect based upon the number of Common Shares actually issued and remaining issuable after such expiry
    and shall be further readjusted in such manner upon the expiry of any further such right. Any Warrantholder who has not exercised
    his right to subscribe for and purchase Common Shares on or prior to the record date of such stock dividend or distribution
    or the effective date of such subdivision or consolidation, as the case may be, upon the exercise of such right thereafter
    shall be entitled to receive and shall accept in lieu of the number of Common Shares then subscribed for and purchased by
    such Warrantholder, at the Exercise Price determined in accordance with this clause 9(a)(i) the aggregate number of Common
    Shares that such Warrantholder would have been entitled to receive as a result of such Common Share Reorganization, if, on
    such record date or effective date, as the case may be, such Warrantholder had been the holder of record of the number of
    Common Shares so subscribed for and purchased.
	 	 	 
	 	ii.	If
    at any time during the Adjustment Period the Corporation shall fix a record date for the issue or distribution to the holders
    of all or substantially all of the outstanding Common Shares of rights, options or warrants pursuant to which such holders
    are entitled, during a period expiring not more than 45 days after the record date for such issue (such period being the “Rights
    Period”), to subscribe for or purchase Common Shares or securities exchangeable for or convertible into Common Shares
    at a price per share to the holder (or in the case of securities exchangeable for or convertible into Common Shares, at an
    exchange or conversion price per share) at the date of issue of such securities of less than 95% of the Current Market Price
    of the Common Shares on such record date (any of such events being called a “Rights Offering”), the Exercise
    Price shall be adjusted effective immediately after the record date for such Rights Offering to the amount determined by multiplying
    the Exercise Price in effect on such record date by a fraction:

 

	 	1)	the
    numerator of which shall be the aggregate of

 

	 	A.	the
    number of Common Shares outstanding on the record date for the Rights Offering, and
	 	 	 
	 	B.	the
    quotient determined by dividing

 

	 	I.	either
    (a) the product of the number of Common Shares offered during the Rights Period pursuant to the Rights Offering and the price
    at which such Common Shares are offered, or, (b) the product of the exchange or conversion price of the securities so offered
    and the number of Common Shares for or into which the securities offered pursuant to the Rights Offering may be exchanged
    or converted, as the case may be, by
	 	 	 
	 	II.	the
    Current Market Price of the Common Shares as of the record date for the Rights Offering; and

 

    	 

    8

    

 

 

	 	2)	the
    denominator of which shall be the aggregate of the number of Common Shares outstanding on such record date and the number
    of Common Shares offered pursuant to the Rights Offering (including in the case of the issue or distribution of securities
    exchangeable for or convertible into Common Shares the number of Common Shares for or into which such securities may be exchanged
    or converted).

 

	 	 	If
    by the terms of the rights, options, or warrants referred to in this clause 9(a)(ii), there is more than one purchase, conversion
    or exchange price per Common Share, the aggregate price of the total number of additional Common Shares offered for subscription
    or purchase, or the aggregate conversion or exchange price of the convertible or exchangeable securities so offered, shall
    be calculated for purposes of the adjustment on the basis of the lowest purchase, conversion or exchange price per Common
    Share, as the case may be. Any Common Shares owned by or held for the account of the Corporation shall be deemed not to be
    outstanding for the purpose of any such calculation. To the extent that any adjustment in the Exercise Price occurs pursuant
    to this clause 9(a)(ii) as a result of the fixing by the Corporation of a record date for the issue or distribution of rights,
    options or warrants referred to in this clause 9(a)(ii), the Exercise Price shall be readjusted immediately after the expiry
    of any relevant exchange, conversion or exercise right to the Exercise Price which would then be in effect based upon the
    number of Common Shares actually issued and remaining issuable after such expiry and shall be further readjusted in such manner
    upon the expiry of any further such right.
	 	 	 
	 	iii.	If
    at any time during the Adjustment Period the Corporation shall fix a record date for the issue or distribution to the holders
    of all or substantially all of the outstanding Common Shares of:

 

	 	1)	shares
    of the Corporation of any class other than Common Shares;
	 	 	 
	 	2)	rights,
    options or warrants to acquire Common Shares or securities exchangeable for or convertible into Common Shares (other than
    rights, options or warrants pursuant to which holders of Common Shares are entitled, during a period expiring not more than
    45 days after the record date for such issue, to subscribe for or purchase Common Shares or securities exchangeable for or
    convertible into Common Shares at a price per share (or in the case of securities exchangeable for or convertible into Common
    Shares at an exchange or conversion price per share) at the date of issue of such securities to the holder of at least 95%
    of the Current Market Price of the Common Shares on such record date);
	 	 	 
	 	3)	evidences
    of indebtedness of the Corporation; or

 

    	 

    9

    

 

	 	4)	any
    property or assets of the Corporation;

 

and
if such issue or distribution does not constitute a Common Share Reorganization or a Rights Offering (any of such non-excluded
events being herein called a “Special Distribution”), the Exercise Price shall be adjusted effective immediately
after the record date for the Special Distribution to the amount determined by multiplying the Exercise Price in effect on the
record date for the Special Distribution by a fraction:

 

	 	A.	the
    numerator of which shall be the difference between

 

	 	I.	the
    product of the number of Common Shares outstanding on such record date and the Current Market Price of the Common Shares on
    such record date, and
	 	 	 
	 	II.	the
    fair value, as determined by the directors of the Corporation, to the holders of Common Shares of the shares, rights, options,
    warrants, evidences of indebtedness or property or assets to be issued or distributed in the Special Distribution, and

 

	 	B.	the
    denominator of which shall be the product obtained by multiplying the number of Common Shares outstanding on such record date
    by the Current Market Price of the Common Shares on such record date.

 

Any
Common Shares owned by or held for the account of the Corporation shall be deemed not to be outstanding for the purpose of such
calculation. To the extent that any adjustment in the Exercise Price occurs pursuant to this clause 9(a)(iii) as a result of the
fixing by the Corporation of a record date for the issue or distribution of rights, options or warrants to acquire Common Shares
or securities exchangeable for or convertible into Common Shares referred to in this clause 9(a)(iii), the Exercise Price shall
be readjusted immediately after the expiry of any relevant exercise, exchange or conversion right to the amount which would then
be in effect based upon the number of Common Shares issued and remaining issuable after such expiry and shall be further readjusted
in such manner upon the expiry of any further such right.

 

	 	iv.	If
    at any time during the Adjustment Period there shall occur:

 

	 	1)	a
    reclassification or redesignation of the Common Shares, a change of the Common Shares into other shares or securities or any
    other capital reorganization involving the Common Shares other than a Common Share Reorganization;

 

    	 

    10

    

 

	 	2)	a
    consolidation, amalgamation or merger of the Corporation or other form of business combination with or into another body corporate
    which results in a reclassification or redesignation of the Common Shares or a change of the Common Shares into other shares
    or securities;
	 	 	 
	 	3)	the
    transfer of the undertaking or assets of the Corporation as an entirety or substantially as an entirety to another corporation
    or entity;

 

	 	 	(any
    of such events being called a “Capital Reorganization”), after the effective date of the Capital Reorganization
    the Warrantholder shall be entitled to receive, and shall accept, for the same aggregate consideration, upon exercise of the
    Warrants, in lieu of the number of Common Shares to which the Warrantholder was theretofor entitled upon the exercise of the
    Warrants, the kind and aggregate number of shares and other securities or property resulting from the Capital Reorganization
    which the Warrantholder would have been entitled to receive as a result of the Capital Reorganization if, on the effective
    date thereof, the Warrantholder had been the registered holder of the number of Common Shares which the Warrantholder was
    theretofore entitled to purchase or receive upon the exercise of the Warrants. If necessary, as a result of any such Capital
    Reorganization, appropriate adjustments shall be made in the application of the provisions of this Warrant Certificate with
    respect to the rights and interests thereafter of the Warrantholder to the end that the provisions shall thereafter correspondingly
    be made applicable as nearly as may reasonably be possible in relation to any shares or other securities or property thereafter
    deliverable upon the exercise of the Warrants.
	 	 	 
	 	v.	If
    at any time during the Adjustment Period any adjustment or readjustment in the Exercise Price shall occur pursuant to the
    provisions of clause 9(a)(i), 9(a)(ii) or 9(a)(iii) of this Warrant Certificate, then the number of Common Shares purchasable
    upon the subsequent exercise of the Warrants shall be simultaneously adjusted or readjusted, as the case may be, by multiplying
    the number of Common Shares purchasable upon the exercise of the Warrants immediately prior to such adjustment or readjustment
    by a fraction which shall be the reciprocal of the fraction used in the adjustment or readjustment of the Exercise Price.

 

	 	b)	Rules:
    The following rules and procedures shall be applicable to adjustments made pursuant to subsection 9(a) hereof:

 

	 	i.	Subject
    to the following clauses of this subsection 9(b), any adjustment made pursuant to subsection 9(a) hereof shall be made successively
    whenever an event referred to therein shall occur.

 

    	 

    11

    

 

	 	ii.	No
    adjustment in the Exercise Price shall be required unless such adjustment would result in a change of at least one per cent
    in the then Exercise Price and no adjustment shall be made in the number of Common Shares purchasable or issuable on the exercise
    of the Warrants unless it would result in a change of at least one one-hundredth of a Common Share; provided, however, that
    any adjustments which except for the provision of this clause 9(b)(ii) would otherwise have been required to be made shall
    be carried forward and taken into account in any subsequent adjustment. Notwithstanding any other provision of subsection
    9(a) hereof, no adjustment of the Exercise Price shall be made which would result in an increase in the Exercise Price or
    a decrease in the number of Common Shares issuable upon the exercise of the Warrants (except in respect of the Common Share
    Reorganization described in subclause 9(a)(i)(4) hereof or a Capital Reorganization described in subclause 9(a)(iv)(2) hereof).
	 	 	 
	 	iii.	No
    adjustment in the Exercise Price or in the number or kind of securities purchasable upon the exercise of the Warrants shall
    be made in respect of any event described in section 9 hereof if the Warrantholder is entitled to participate in such event
    on the same terms mutatis mutandis as if the Warrantholder had exercised the Warrants prior to or on the record date
    or effective date, as the case may be, of such event.
	 	 	 
	 	iv.	No
    adjustment in the Exercise Price or in the number of Common Shares purchasable upon the exercise of the Warrants shall be
    made pursuant to subsection 9(a) hereof in respect of the issue from time to time of Common Shares pursuant to this Warrant
    Certificate or pursuant to any stock option, stock purchase or stock bonus plan in effect from time to time for directors,
    officers or employees of the Corporation and/or any subsidiary of the Corporation and any such issue, and any grant of options
    in connection therewith, shall be deemed not to be a Common Share Reorganization, a Rights Offering nor any other event described
    in subsection 9(a) hereof.
	 	 	 
	 	v.	If
    at any time during the Adjustment Period the Corporation shall take any action affecting the Common Shares, other than an
    action described in subsection 9(a) hereof, which in the opinion of the directors would have a material adverse effect upon
    the rights of Warrantholders, either or both the Exercise Price and the number of Common Shares purchasable upon exercise
    of Warrants shall be adjusted in such manner and at such time by action by the directors, in their sole discretion, as may
    be equitable in the circumstances. Failure of the taking of action by the directors so as to provide for an adjustment prior
    to the effective date of any action by the Corporation affecting the Common Shares shall be deemed to be conclusive evidence
    that the directors have determined that it is equitable to make no adjustment in the circumstances.
	 	 	 
	 	vi.	If
    the Corporation shall set a record date to determine holders of Common Shares for the purpose of entitling such holders to
    receive any dividend or distribution or any subscription or purchase rights and shall, thereafter and before the distribution
    to such holders of any such dividend, distribution or subscription or purchase rights, legally abandon its plan to pay or
    deliver such dividend, distribution or subscription or purchase rights, then no adjustment in the Exercise Price or the number
    of Common Shares purchasable upon exercise of the Warrant shall be required by reason of the setting of such record date.

 

    	 

    12

    

 

	 	vii.	In
    any case in which this Warrant Certificate shall require that an adjustment shall become effective immediately after a record
    date for an event referred to in subsection 9(a) hereof, the Corporation may defer, until the occurrence of such event:

 

	 	1)	issuing
    to the Warrantholder, to the extent that the Warrants are exercised after such record date and before the occurrence of such
    event, the additional Common Shares or other securities issuable upon such exercise by reason of the adjustment required by
    such event; and
	 	 	 
	 	2)	delivering
    to the Warrantholder any distribution declared with respect to such additional Common Shares or other securities after such
    record date and before such event;

 

	 	 	provided,
    however, that the Corporation shall deliver to the Warrantholder an appropriate instrument evidencing the right of the Warrantholder
    upon the occurrence of the event requiring the adjustment, to an adjustment in the Exercise Price or the number of Common
    Shares purchasable upon the exercise of the Warrants and to such distribution declared with respect to any such additional
    Common Shares issuable on the exercise of the Warrants.
	 	 	 
	 	viii.	In
    the absence of a resolution of the directors fixing a record date for a Rights Offering, the Corporation shall be deemed to
    have fixed as the record date therefor the date of the issue of the rights, options or warrants issued pursuant to the Rights
    Offering.
	 	 	 
	 	ix.	If
    a dispute shall at any time arise with respect to adjustments of the Exercise Price or the number of Common Shares purchasable
    upon the exercise of the Warrants, such disputes shall be conclusively determined by the auditors of the Corporation or if
    they are unable or unwilling to act, by such other firm of independent chartered accountants as may be selected by the directors
    and any such determination shall be conclusive evidence of the correctness of any adjustment made pursuant to subsection 9(a)
    hereof and shall be binding upon the Corporation and the Warrantholder.
	 	 	 
	 	x.	As
    a condition precedent to the taking of any action which would require an adjustment pursuant to subsection 9(a) hereof, including
    the Exercise Price and the number or class of Common Shares or other securities which are to be received upon the exercise
    thereof, the Corporation shall take any action which may, in the opinion of counsel to the Corporation, be necessary in order
    that the Corporation may validly and legally issue as fully paid and non-assessable shares all of the Common Shares or other
    securities which the Warrantholder is entitled to receive in accordance with the provisions of this Warrant Certificate.

 

    	 

    13

    

 

	 	c)	Notice:
    At least 21 days prior to the effective date of any event which requires or might require an adjustment in any of the rights
    of the Warrantholder under this Warrant Certificate, including the Exercise Price or the number of Common Shares which may
    be purchased under this Warrant Certificate, the Corporation shall deliver to the Warrantholder a certificate of the Corporation
    specifying the particulars of such event and, if determinable, the required adjustment and the calculation of such adjustment.
    In case any adjustment for which a notice in this subsection 9(c) has been given is not then determinable, the Corporation
    shall promptly after such adjustment is determinable deliver to the Warrantholder a certificate providing the calculation
    of such adjustment. The Corporation hereby covenants and agrees that the register of transfers and share transfer books for
    the Common Shares will be open, and that the Corporation will not take any action which might deprive the Warrantholder of
    the opportunity of exercising the rights of subscription contained in this Warrant Certificate, during such 21 day period.

 

	10.	Lost
    Certificate: If this Warrant Certificate or any replacement hereof becomes stolen, lost, mutilated or destroyed, the Corporation
    shall, on such terms as it may in its discretion impose, acting reasonably, issue and deliver a new certificate, in form identical
    hereto but with appropriate changes, representing any unexercised portion of the subscription rights represented hereby to
    replace the certificate so stolen, lost, mutilated or destroyed.
	 	 
	11.	Further
    Assurances: The Corporation hereby covenants and agrees that it will do, execute, acknowledge and deliver, or cause to
    be done, executed, acknowledged and delivered, all and every such other act, deed and assurance as the Warrantholder shall
    reasonably require for the better accomplishing and effectuating of the intentions and provisions of this Warrant Certificate.
	 	 
	12.	Time
    of Essence: Time shall be of the essence of this Warrant Certificate.
	 	 
	13.	Governing
    Laws: This Warrant Certificate shall be construed in accordance with the laws of the Province of British Columbia and
    the federal laws of Canada applicable therein.
	 	 
	14.	Notices:
    All notices or other communications to be given under this Warrant Certificate shall be delivered by hand or by telecopier
    and, if delivered by hand, shall be deemed to have been given on the delivery date and, if sent by telecopier, on the date
    of transmission if sent before 4:00 p.m. on a business day or, if such day is not a business day, on the first business day
    following the date of transmission.

 

Notices
to the Corporation shall be addressed to:

 

Canivate
Growing Systems Ltd.

Suite
500, 1112 West Pender Street

Vancouver,
British Columbia

Canada
V6E 2S1

 

Attention:
Mr. Ingo Mueller, C.E.O.

E-mail
Address: ingo.mueller@canivate.com

 

Notices
to the Warrantholder shall be addressed to the address of the Warrantholder set out on the face page of this Warrant Certificate.

 

The
Corporation and the Warrantholder may change its address for service by notice in writing to the other of them specifying its
new address for service under this Warrant Certificate.

 

	15.	Language:
    The parties hereto acknowledge and confirm that they have requested that this Warrant Certificate as well as all notices
    and other documents contemplated hereby be drawn up in the English language. Les parties aux présentes reconnaissent
    et confirment qu’elles ont exigé que la présente convention ainsi que tous les avis et documents qui s’y
    rattachent soient rédigés en langue anglaise.
	 	 
	16.	Successors
    and Assigns: This Warrant Certificate shall enure to the benefit of the Warrantholder and the successors and assignees
    thereof and shall be binding upon the Corporation and the successors thereof.

 

[REST
OF PAGE INTENTIONALLY LEFT BLANK]

 

    	 

    14

    

 

SCHEDULE
“B”

 

SUBSCRIPTION
FORM

(Non-U.S. Warrantholders)

 

TO:
CANIVATE GROWING SYSTEMS LTD.

 

The
undersigned hereby subscribes for ____________ common shares (“Common Shares”) of Canivate Growing Systems
Ltd. (the “Corporation”) (or such other number of Common Shares or other securities to which such subscription
entitles the undersigned in lieu thereof or in addition thereto) pursuant to the provisions of the warrant certificate (the “Warrant
Certificate”) dated May 2, 2019 issued by the Corporation to the Warrantholder (as defined in the Warrant Certificate)
at the purchase price of $2.00 (Cdn) per Common Share (or at such other purchase price as may then be in effect under the provisions
of the Warrant Certificate) and on and subject to the other terms and conditions specified in the Warrant and encloses herewith
a cheque, bank draft or money order or has transmitted good same day funds by wire or other similar transfer in lawful money of
Canada payable to or to the order of the Corporation in payment of the subscription price.

 

By
executing this subscription form the undersigned represents and warrants that the undersigned at the time of execution and delivery
of this subscription form (i) is not in the United States and is not a “U.S. Person” (as defined in Regulation S promulgated
under the United States Securities Act of 1933, as amended, (the “U.S. Securities Act”)); (ii) is not exercising
the right provided for herein for the account or benefit of a U.S. Person or a person in the United States (as defined in Regulation
S); (iii) is not exercising Warrants with the intent to distribute either directly or indirectly any of the securities acquirable
upon exercise in the United States, except in compliance with the U.S. Securities Act; and (iv) has in all other respects complied
with the terms of Regulation S of the U.S. Securities Act.

 

The
undersigned hereby directs that the Common Shares subscribed for be registered and delivered as follows:

 

	Name
    in Full	 	Address
    (include Postal Code)	 	Number
    of Common Shares
	 	 	 	 	 

 

DATED this _______ day of ___________________, 20___.

 

	By:	 	 
	 	Authorized
    Signatory	 

 

    	 

    1

    

 

SCHEDULE
“C”

 

SUBSCRIPTION
FORM

(U.S. Warrantholders)

 

TO:
CANIVATE GROWING SYSTEMS LTD.

 

The
undersigned hereby subscribes for ____________ common shares (“Common Shares”) of Canivate Growing Systems
Ltd. (the “Corporation”) (or such other number of Common Shares or other securities to which such subscription
entitles the undersigned in lieu thereof or in addition thereto) pursuant to the provisions of the warrant certificate (the “Warrant
Certificate”) dated as of issued by the Corporation to the Warrantholder (as defined in the Warrant Certificate) at
the purchase price of $2.00 (Cdn) per Common Share (or at such other purchase price as may then be in effect under the provisions
of the Warrant Certificate) and on and subject to the other terms and conditions specified in the Warrant and encloses herewith
a cheque, bank draft or money order or has transmitted good same day funds by wire or other similar transfer in lawful money of
Canada payable to or to the order of the Corporation in payment of the subscription price.

 

The
undersigned is a resident of the United States or is otherwise subject to the securities laws of the United States and as at the
time of exercise hereunder, the undersigned Warrantholder represents, warrants and certifies [Initial, as appropriate]:

 

	[  ] 	(a)	the
    undersigned Warrantholder is resident in the United States, is a U.S. person, or is exercising the Warrant for the account
    or benefit of a U.S. person or a person in the United States (a “U.S. Holder”), and is an “accredited
    investor”, as defined in Rule 501(a) of Regulation D under the U.S. Securities Act (a “U.S. Accredited Investor”),
    and has completed the U.S. Accredited Investor Status Certificate in the form attached to this subscription form; OR
	 [  ]	(b)	if
    the undersigned Warrantholder is a U.S. Holder, the undersigned Warrantholder has delivered to the Corporation and its registrar
    and transfer agent an opinion of counsel (which will not be sufficient unless it is in form and substance satisfactory to
    the Corporation) or such other evidence satisfactory to the Corporation to the effect that with respect to the Common Shares
    to be delivered upon exercise of the Warrant, the issuance of such securities has been registered under the U.S. Securities
    Act and applicable state securities laws, or an exemption from the registration requirements of the U.S. Securities Act and
    applicable state securities laws is available.

 

Note:
Certificates representing Common Shares will not be registered or delivered to an address in the United States unless box (a)
or (b) immediately above is initialled.

 

If
the undersigned Warrantholder has indicated that the undersigned Warrantholder is a U.S. Accredited Investor by marking box (a)
above, the undersigned Warrantholder additionally represents and warrants to the Corporation that:

 

	1	the
    undersigned Warrantholder has such knowledge and experience in financial and business matters as to be capable of evaluating
    the merits and risks of an investment in the Common Shares, and the undersigned is able to bear the economic risk of loss
    of his or her entire investment;
	 	 
	2.	the
    undersigned: (i) is purchasing the Common Shares for his or her own account or for the account of one or more U.S. Accredited
    Investors with respect to which the undersigned is exercising sole investment discretion, and not on behalf of any other person;
    (ii) is purchasing the Common Shares for investment purposes only and not with a view to resale, distribution or other disposition
    in violation of United States federal or state securities laws; and (iii) in the case of the purchase by the undersigned of
    the Common Shares as agent or trustee for any other person or persons (each a “Beneficial Purchaser”),
    has due and proper authority to act as agent or trustee for and on behalf of each such Beneficial Purchaser in connection
    with the transactions contemplated hereby; provided that: (x) if the undersigned Warrantholder, or any Beneficial Purchaser,
    is a corporation or a partnership, syndicate, trust or other form of unincorporated organization, the undersigned Warrantholder
    or each such Beneficial Purchaser was not incorporated or created solely, nor is it being used primarily to permit purchases
    without a prospectus or registration statement under applicable law; and (y) each Beneficial Purchaser, if any, is a U.S.
    Accredited Investor; and

 

    	 

    2

    

 

	3.	the
    undersigned has not exercised the Warrants as a result of any form of general solicitation or general advertising (as such
    terms are used in Rule 502 of Regulation D under the U.S. Securities Act), including advertisements, articles, notices or
    other communications published in any newspaper, magazine or similar media, or broadcast over radio, television, the Internet
    or other form of telecommunications, or any seminar or meeting whose attendees have been invited by general solicitation or
    general advertising.

 

If
the undersigned has indicated that the undersigned is a U.S. Accredited Investor by marking box (a) above, the undersigned also
acknowledges and agrees that:

 

	1.	the
    Corporation has provided to the undersigned the opportunity to ask questions and receive answers concerning the terms and
    conditions of the offering, and the undersigned has had access to such information concerning the Corporation as the undersigned
    has considered necessary or appropriate in connection with the undersigned’s investment decision to acquire the Common
    Shares;
	 	 
	2.	if
    the undersigned decides to offer, sell or otherwise transfer any of the Common Shares, the undersigned must not, and will
    not, offer, sell or otherwise transfer any of such Common Shares directly or indirectly, unless:

 

	 	(a)	the
    sale is to the Corporation;
	 	 	 
	 	(b)	the
    sale is made outside the United States in a transaction meeting the requirements of Rule 904 of Regulation S under the U.S.
    Securities Act and in compliance with applicable local laws and regulations;
	 	 	 
	 	(c)	the
    sale is made pursuant to the exemption from the registration requirements under the U.S. Securities Act provided by Rules
    144 or 144A thereunder, if available, and in accordance with any applicable state securities or “blue sky” laws;
    or
	 	 	 
	 	(d)	the
    Common Shares are sold in a transaction that does not require registration under the U.S. Securities Act or any applicable
    state laws and regulations governing the offer and sale of securities, and it has prior to such sale furnished to the Corporation
    an opinion of counsel reasonably satisfactory to the Corporation;

 

    	 

    3

    

 

	3.	the
    Common Shares are “restricted securities” under applicable federal securities laws and that the U.S. Securities
    Act and the rules of the United States Securities and Exchange Commission provide in substance that the undersigned may dispose
    of the Common Shares only pursuant to an effective registration statement under the U.S. Securities Act or an exemption therefrom;
	 	 
	4.	the
    Corporation has no obligation to register any of the Common Shares or to take action so as to permit sales pursuant to the
    U.S. Securities Act (including Rule 144 thereunder);
	 	 
	5.	the
    certificates representing the Common Shares (and any certificates issued in exchange or substitution for the Common Shares)
    will bear a legend stating that such securities have not been registered under the U.S. Securities Act or the securities laws
    of any state of the United States, and may not be offered for sale or sold unless registered under the U.S. Securities Act
    and the securities laws of all applicable states of the United States, or unless an exemption from such registration requirements
    is available;
	 	 
	6.	delivery
    of certificates bearing such a legend may not constitute “good delivery” in settlement of transactions on Canadian
    stock exchanges or over-the-counter markets, but if the Corporation is a “foreign issuer” (within the meaning
    of Regulation S promulgated under the U.S. Securities Act) at the time of sale, a new certificate will be made available to
    the undersigned upon provision by the undersigned of a declaration to the Corporation and its registrar and transfer agent
    (the “Transfer Agent”) in the form attached as Schedule “C” hereto (or in such other form as
    the Corporation may prescribe from time to time) and, if requested by the Corporation or the Transfer Agent, an opinion of
    counsel of recognized standing in form and substance satisfactory to the Corporation and the Transfer Agent to the effect
    that such sale is being made in compliance with Rule 904 of Regulation S; and provided, further, that, if any Common Shares
    are being sold otherwise than in accordance with Rule 904 of Regulation S and other than to the Corporation, the legend may
    be removed by delivery to the Transfer Agent and the Corporation of an opinion of counsel, of recognized standing reasonably
    satisfactory to the Corporation, that such legend is no longer required under applicable requirements of the U.S. Securities
    Act or state securities laws;
	 	 
	7.	the
    financial statements of the Corporation have been prepared in accordance with Canadian generally accepted accounting principles
    or International Financial Reporting Standards, which differ in some respects from United States generally accepted accounting
    principles, and thus may not be comparable to financial statements of United States companies;
	 	 
	8.	there
    may be material tax consequences to the undersigned of an acquisition or disposition of the Common Shares;
	 	 
	9.	the
    Corporation gives no opinion and makes no representation with respect to the tax consequences to the undersigned under United
    States, state, local or foreign tax law of the undersigned’s acquisition or disposition of any Common Shares; in particular,
    no determination has been made whether the Corporation will be a “passive foreign investment company” (commonly
    known as a “PFIC”) within the meaning of Section 1297 of the United States Internal Revenue Code;
	 	 
	10.	funds
    representing the subscription price for the Common Shares which will be advanced by the undersigned to the Corporation upon
    exercise of the Warrants will not represent proceeds of crime for the purposes of the United States Uniting and Strengthening
    America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act (the “PATRIOT Act”),
    and the undersigned acknowledges that the Corporation may in the future be required by law to disclose the undersigned’s
    name and other information relating to this exercise form and the undersigned’s subscription hereunder, on a confidential
    basis, pursuant to the PATRIOT Act. No portion of the subscription price to be provided by the undersigned (i) has been or
    will be derived from or related to any activity that is deemed criminal under the laws of the United States of America, or
    any other jurisdiction, or (ii) is being tendered on behalf of a person or entity who has not been identified to or by the
    undersigned, and it shall promptly notify the Corporation if the undersigned discovers that any of such representations ceases
    to be true and provide the Corporation with appropriate information in connection therewith;

 

	11.	the
    Corporation is not obligated to remain a “foreign issuer”; and
	 	 
	12.	the
    undersigned consents to the Corporation making a notation on its records or giving instructions to any transfer agent of the
    Corporation in order to implement the restrictions on transfer set forth and described in this subscription form.

 

The
undersigned hereby directs that the Common Shares subscribed for be registered and delivered as follows:

 

	Name
    in Full	 	Address
    (include Postal Code)	 	Number
    of Common Shares
	 	 	 	 	 

 

DATED
this _______ day of ___________________, 20___.

 

	By:	 	 
	 	Authorized
    Signatory	 

 

    	 

    1

    

 

APPENDIX
C-1

 

U.S.
ACCREDITED INVESTOR STATUS CERTIFICATE

 

TO:
CANIVATE GROWING SYSTEMS LTD.

 

In
connection with the purchase by the undersigned or the disclosed principal, the undersigned (the “Purchaser”)
hereby represents and warrants that the Purchaser (and, if the Purchaser is acting on behalf of a beneficial purchaser, such beneficial
purchaser) is an “Accredited Investor”, as defined in Rule 501(a) under the United States Securities Act of 1933,
as amended (the “U.S. Securities Act”) as a result of satisfying one or more of the following categories of
Accredited Investor below to which the undersigned has affixed his or her initials (the line identified as “BP” is
to be initialed by the beneficial purchaser, if any, on each line that applies).

 

	__________

                                                                         

        __________  (BP)
	a
    natural person whose individual net worth, or joint net worth with that person’s spouse, at the time of his or her purchase
    exceeds US$1,000,000 (for the purposes of calculating net worth: (i) the person’s primary residence shall not be included
    as an asset; (ii) indebtedness that is secured by the person’s primary residence, up to the estimated fair market value
    of the primary residence at the time of the sale and purchase of securities contemplated by the accompanying Subscription
    Form, shall not be included as a liability (except that if the amount of such indebtedness outstanding at the time of the
    sale and purchase of securities contemplated by the accompanying Subscription Form exceeds the amount outstanding 60 days
    before such time, other than as a result of the acquisition of the primary residence, the amount of such excess shall be included
    as a liability); and (iii) indebtedness that is secured by the person’s primary residence in excess of the estimated
    fair market value of the primary residence shall be included as a liability).
	 	 
	

                                         _________

         

        _________   (BP)
	A
    natural person who had annual gross income during each of the last two full calendar years in excess of US$200,000 (or together
    with his or her spouse in excess of US$300,000) and reasonably expects to have annual gross income in excess of US$200,000
    (or together with his or her spouse in excess of US$300,000) during the current calendar year, and no reason to believe that
    his or her annual gross income will not remain in excess of US$200,000 (or that together with his or her spouse will not remain
    in excess of US$300,000) for the foreseeable future;
	 	 
	

                                         _________

         

        _________   (BP)
	Any
    bank as defined in Section 3(a)(2) of the United States Securities Act of 1933, as amended (the “U.S. Securities
    Act”), or any savings and loan association or other institution as defined in Section 3(a)(5)(A) of the U.S. Securities
    Act whether acting in its individual or fiduciary capacity; any broker or dealer registered pursuant to Section 15 of the
    U.S. Securities Exchange Act of 1934; any insurance company as defined in Section 2(a)(13) of the U.S. Securities Act; any
    investment company registered under the U.S. Investment Company Act of 1940 or a business development company as defined in
    Section 2(a)(48) of that Act; any Small Business Investment Company licensed by the U.S. Small Business Administration under
    Section 301(c) or (d) of the U.S. Small Business Investment Act of 1958; any plan established and maintained by a state, its
    political subdivisions, or any agency or instrumentality of a state or its political subdivisions, for the benefit of its
    employees, if such plan has total assets in excess of US$5,000,000; any employee benefit plan within the meaning of the U.S.
    Employee Retirement Income Security Act of 1974 if the investment decision is made by a plan fiduciary, as defined in Section
    3(21) of such Act, which is either a bank, savings and loan association, insurance company, or registered investment adviser,
    or if the employee benefit plan has total assets in excess of US$5,000,000, or, if a self-directed plan, with investment decisions
    made solely by persons that are “accredited investors” (as such term is defined in Rule 501 of Regulation D of
    the U.S. Securities Act).

 

    	 

    2

    

 

	_________

                                                                      

                                                                     _________   (BP)
	Any
    private business development company as defined in Section 202(a)(22) of the U.S. Investment Advisers Act of 1940.
	 	 
	

_________

                                                          

                                                         

                                                         _________   (BP)
	Any
    organization described in Section 501(c)(3) of the U.S. Internal Revenue Code, corporation, Massachusetts or similar business
    trust, or partnership, not formed for the specific purpose of acquiring the securities offered, with total assets in excess
    of US$5,000,000.
	 	 
	

        _________

         

        _________   (BP)
	Any
    director or executive officer of Canivate Growing Systems Ltd.
	 	 
	_________

         

        _________   (BP)
	Any
    trust with total assets in excess of US$5,000,000, not formed for the specific purpose of acquiring the securities offered,
    whose purchase is directed by a sophisticated person (being defined as a person who has such knowledge and experience in financial
    and business matters that he or she is capable of evaluating the merits and risks of the prospective investment).
	 	 
	_________

                                                          

                                                         _________   (BP)
	Any
    entity in which all of the equity owners meet the requirements of at least one of the above categories.

 

DATED
at  this day of _______________, 20__.

 

	 	By:	 
	 	Name:	
	 	Title:	 

 

    	 

    1

    

 

SCHEDULE
“D”

 

FORM
OF DECLARATION FOR REMOVAL OF LEGEND

 

	TO:	Canivate
                                         Growing Systems Ltd. (the “Corporation”)

        

	 	 
	AND
    TO:	The
                                         registrar and transfer agent for the securities of Canivate Growing Systems Ltd.

        

 

The
undersigned (A) acknowledges that the sale of the ________________ Common Shares in the capital of the Corporation represented
by certificate number _______________, to which this declaration relates, is being made in reliance on Rule 904 of Regulation
S under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), and (B) certifies
that (1) the undersigned is not an “affiliate” (as defined in Rule 405 under the U.S. Securities Act) of the Corporation
or a “distributor”, as defined in Regulation S, or an affiliate of a “distributor”; (2) the offer of such
securities was not made to a person in the United States and either (a) at the time the buy order was originated, the buyer was
outside the United States, or the seller and any person acting on its behalf reasonably believe that the buyer was outside the
United States, or (b) the transaction was executed on or through the facilities of the Canadian Securities Exchange or any other
designated offshore securities market within the meaning of Rule 902(b) of Regulation S under the U.S. Securities Act, and neither
the seller nor any person acting on its behalf knows that the transaction has been prearranged with a buyer in the United States;
(3) neither the seller nor any affiliate of the seller nor any person acting on their behalf has engaged in any directed selling
efforts in connection with the offer and sale of such securities; (4) the sale is bona fide and not for the purpose of “washing
off” the resale restrictions imposed because the securities are “restricted securities” (as such term is defined
in Rule 144(a)(3) under the U.S. Securities Act); (5) the seller does not intend to replace the securities sold in reliance on
Rule 904 of Regulation S under the U.S. Securities Act with fungible unrestricted securities; and (6) the contemplated sale is
not a transaction, or part of a series of transactions which, although in technical compliance with Regulation S, is part of a
plan or a scheme to evade the registration provisions of the U.S. Securities Act. Unless otherwise specified, terms used herein
have the meanings given to them by Regulation S under the U.S. Securities Act.

 

Dated:
____________________________

 

	 	 
	Signature
    of individual (if Seller is an individual)	 
	 	 
	 	 
	Authorized
    signatory (if Seller is not an individual)	 
	 	 
	 	 
	Name
    of Seller (please print)	 
	 	 
	 	 
	Name
    of authorized signatory (please print)	 
	 	 
	 	 
	Official
    capacity of authorized signatory (please print)	 

 

    	 

    2

    

 

Affirmation
by Seller’s Broker-Dealer (Required for sale pursuant to paragraph (B)(2)(b) above)

 

We
have read the foregoing representations of our customer, _________________________ (the “Seller”) dated _______________________,
with regard to the sale, for such Seller’s account, of the securities of the Corporation described therein, and we hereby
affirm that: (a) we have no knowledge that the transaction had been prearranged with a buyer in the United States; (b) the transaction
was executed on or through the facilities of the Canadian Securities Exchange or another “designated offshore securities
market”; (c) neither we, nor any person acting on our behalf, engaged in any directed selling efforts in connection with
the offer and sale of such securities, and (d) no selling concession, fee or other remuneration is being paid to us in connection
with this offer and sale other than the usual and customary broker’s commission that would be received by a person executing
such transaction as agent. Terms used herein have the meanings given to them by Regulation S under the U.S. Securities Act.

 

	 	 	 
	 	Name
    of Firm	 
	 	 	 
	By:
    		 
	 	Authorized
    officer	 
	 	 	 
	Date:	 	 

 

    	 

     

    

 

SCHEDULE
“E”

FORM
OF TRANSFER

 

FOR
VALUE RECEIVED, the undersigned hereby sells, assigns and transfers unto

_______________________________________________________________________________________________ 

(include name and address of the transferee) Warrants exercisable for common shares of Canivate Growing Systems Ltd. (the “Corporation”)
registered in the name of the undersigned on the register of the Corporation maintained therefor, and hereby irrevocably appoints

the attorney of the undersigned to transfer the said securities on the books maintained by the Corporation with full power
of substitution.

 

DATED
this _______ day of ___________________, 20___.

 

Signature
of Transferor guaranteed by:

 

	 	 	 
	Medallion
    Signature Guarantee	 	Signature
    of Transferor
	Stamp
    of Transferor	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	Address
    of Transferor

 

The
Transferor hereby certifies that:

 

(check
one)

 

	[  ]	the
    transferee was not offered the Warrants in the United States and is not in the United States or a “U.S. Person”
    (as defined in Regulation S under the United States Securities Act of 1933, as amended (the “U.S. Securities
    Act”)), and is not acquiring the Warrants for the account or benefit of a person in the United States or a U.S.
    Person; or
	 	 
	[  ]	enclosed
    herewith is an opinion of counsel (which the transferee understands must be satisfactory to the Corporation) to the effect
    that no violation of the U.S. Securities Act or applicable securities laws will result from transfer, exercise or deemed exercise
    of the Warrants.

 

It
is understood that the Corporation may require additional evidence necessary to verify the foregoing.

 

INSTRUCTIONS
FOR TRANSFER

 

	1.	The
    signature of the Warrantholder must correspond with the name written upon the face of this Warrant Certificate in every particular
    without any changes whatsoever.
	 	 
	2.	If
    the Transfer Form is signed by a trustee, executor, administrator, curator, guardian, attorney, officer of a corporation or
    any person acting in a fiduciary or representative capacity, the certificate must be accompanied by evidence of authority
    to sign satisfactory to the Corporation.
	 	 
	3.	The
    signature on the Transfer Form must be guaranteed by a chartered back or trust company, or a member firm of an approved signature
    guarantee medallion program. The guarantor must affix a stamp bearing the actual words: “SIGNATURE GUARANTEED”.
	 	 
	4.	The
    Warrants will only be transferable in accordance with applicable laws. The Warrants and the common shares issuable upon exercise
    thereof have not been and will not be registered under the U.S. Securities Act, or under the securities laws of any state
    of the United States, and may not be transferred to or for the account or benefit of a U.S. person or any person in the United
    States without registration under the U.S. Securities Act and applicable state securities laws, or compliance with the requirements
    of an exemption from registration. “United States” and “U.S. Person” are as defined in Regulation
    S under the U.S. Securities Act.Exhibit 4.5

 

UNLESS
PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY MUST NOT TRADE THE SECURITY BEFORE THE DATE THAT IS 4 MONTHS
AND A DAY AFTER THE LATER OF (I) MAY 2, 2019, AND (II) THE DATE THE CORPORATION
BECAME A REPORTING ISSUER IN ANY PROVINCE OR TERRITORY OF CANADA.

 

THE
WARRANT EVIDENCED HEREBY IS EXERCISABLE ON OR BEFORE 5:00 PM (VANCOUVER TIME) ON MAY 2,
2024, SUBJECT TO ACCELERATION OF THE EXPIRY DATE AS SET FORTH HEREIN, AFTER WHICH TIME THE WARRANTS EVIDENCED HEREBY SHALL
BE DEEMED TO BE VOID AND OF NO FURTHER FORCE OR EFFECT.

 

THE
WARRANTS REPRESENTED HEREBY MAY NOT BE SOLD, TRANSFERRED, ASSIGNED, HYPOTHECATED OR OTHERWISE TRADED.

 

CANIVATE
GROWING SYSTEMS LTD.

(Incorporated under the laws of British Columbia)

 

	Certificate
    Number: [●]	[●]
    Warrants to Purchase Units

 

(NON-TRANSFERABLE)

 

COMPENSATION
WARRANTS

 

THIS
IS TO CERTIFY THAT, for value received, [●] of [●] or its lawful assignee (the “Holder”) is the registered
holder of [●] compensation warrants (collectively the “Compensation Warrants” and each a “Compensation
Warrant”), each of which entitles the Holder to subscribe for and purchase one unit (collectively the “Units”
and each a “Unit”) of Canivate Growing Systems Ltd. (the “Company”) at any time on or before
5:00 p.m. Vancouver time on May 2, 2024 (the “Expiry Date”), subject to acceleration as provided in Part 4
of Schedule A to this Compensation Warrant Certificate, at a price of $1.00 per Unit, subject to the provisions and upon the Terms
and Conditions attached hereto as Schedule “A”. Each Unit will consist of one (1) Series A preferred share (a “Preferred
Share”) in the capital of the Company and one common share purchase warrant (a “Common Share Warrant”),
subject to adjustment as provided for herein. Each Common Share Warrant will entitle the holder thereof to purchase one common
share (a “Common Share”) of the Company at a price of $2.00 per Common Share at any time before 5:00p.m. (Vancouver
time) on May 2, 2024, subject to acceleration.

 

The
rights represented by this Compensation Warrant Certificate may be exercised by the Holder, in whole or in part (but not as to
a fraction of a Unit) by surrender of this Compensation Warrant Certificate (properly endorsed as required), together with a Warrant
Exercise Form in the form attached hereto as Appendix “B”, duly completed and executed, to the Company at Suite 500,
1112 West Pender Street, Vancouver, BC V6G 2S1 (Attention: Chief Financial Officer), or such other address as the Company may
from time to time in writing direct, together with a certified cheque or bank draft payable to or to the order of the Company
in payment of the purchase price of the number of Units subscribed for. The Holder is advised to read “Instruction to Holders”
attached hereto as Appendix “A” for details on how to complete the Warrant Exercise Form (as such term is defined
in Schedule “A”).

 

[Signature
Page Follows]

 

    	 

    	 

    

 

IN
WITNESS WHEREOF the Company has caused this Compensation Warrant Certificate to be executed by its duly authorized officer,
this 2nd day of May, 2019.

 

	CANIVATE
    GROWING SYSTEMS LTD. 	 
	 	 	 
	Per:	     	 
	 	Authorized
    Signatory	 

 

[Signature
Page to Finder’s Warrants]

 

    	 

    	 

    

 

SCHEDULE
“A”

 

TERMS
AND CONDITIONS

ATTACHED TO COMPENSATION WARRANTS

ISSUED BY CANIVATE GROWING SYSTEMS LTD.

(the “Company”)

 

Each
Compensation Warrant of the Company, whether single or part of a series, is subject to these Terms and Conditions as they were
at the date of issue of the Compensation Warrant.

 

Part
1

 

DEFINITIONS
AND INTERPRETATION

 

Definitions

 

1.1
In these Terms and Conditions, except as otherwise expressly provided herein, the following words and phrases will have the following
meanings:

 

(a)
“Accelerated Expiry Date” has the meaning set forth in section 4.9 of this Compensation Warrant Certificate;

 

(b)
“Acceleration Notice” has the meaning set forth in section 4.9 of this Compensation Warrant Certificate;

 

(c)
“Common Share Warrant” means a warrant evidenced by a Common Share Warrant Certificate, each entitling the
holder thereof to purchase one (1) Common Share (subject to adjustment) on or before the expiry date at the exercise price set
forth on the Common Share Warrant Certificate;

 

(d)
“Common Share Warrant Certificate” means the certificate evidencing the Common Share Warrant in the form attached
hereto as Schedule “B”;

 

(e)
“Common Shares” means the common shares in the capital of the Company;

 

(f)
“Company” means Canivate Growing Systems Ltd. and includes any successor corporations;

 

(g)
“Company’s auditor” means the accountant duly appointed as auditor of the Company;

 

(h)
“Compensation Warrant” means a warrant as evidenced by a Compensation Warrant Certificate, and each one (1)
Compensation Warrant entitles the holder to purchase one (1) Unit (subject to adjustment) on or before the Expiry Date at the
Exercise Price set forth on the Compensation Warrant Certificate;

 

(i)
“Compensation Warrant Certificate” means the certificate evidencing the Compensation Warrants;

 

(j)
“Exercise Price” means $1.00 per Unit or as may be adjusted in accordance with Part 5;

 

    	 

    	-2-

    

 

(k)
“Expiry Date” means the date defined as such on the face page of this Compensation Warrant Certificate;

 

(l)
“Holder” means the registered holder of a Compensation Warrant;

 

(m)
“person” means an individual, corporation, partnership, trustee or any unincorporated organization, and words
importing persons have a similar meaning;

 

(n)
“Preferred Shares” means the Series A preferred shares in the capital of the Company;

 

(o)
“Unit” means a unit of the Company, with each Unit comprising one (1) Preferred Share (or one (1) Common Share
of the Company if Section 4.2 of this Compensation Warrant applies), and one (1) Common Share Warrant, subject to adjustment as
provided herein; and

 

(p)
“Warrant Exercise Form” means Appendix “B” hereof.

 

Interpretation

 

1.2
In these Terms and Conditions, except as otherwise expressly provided herein:

 

(a)
the words “herein”, “hereof”, and “hereunder” and other words of similar
import refer to this Agreement as a whole and not to any particular Part, clause, subclause or other subdivision;

 

(b)
a reference to a Part means a Part of these Terms and Conditions and the symbol § followed by a number or some combination
of numbers and letters refers to the section, paragraph or subparagraph of these Terms and Conditions so designated;

 

(c)
the headings are for convenience only, do not form a part of these Terms and Conditions and are not intended to interpret, define
or limit the scope, extent or intent of these Terms and Conditions or any of its provisions;

 

(d)
all dollar amounts referred to herein are expressed in Canadian funds;

 

(e)
time will be of the essence hereof; and

 

(f)
words importing the singular number include the plural and vice versa, and words importing the masculine gender include feminine
and neuter genders.

 

Applicable
Law

 

1.3
The Compensation Warrants will be construed in accordance with the laws of the Province of British Columbia and the laws of Canada
applicable thereto and will be treated in all respects as legal contracts under the laws of the Province of British Columbia.

 

    	 

    	-3-

    

 

Part
2

 

ISSUE
OF Compensation WarrantS

 

Issue
in Substitution for Lost Compensation Warrants

 

2.1
In case a Compensation Warrant Certificate will become mutilated, lost, destroyed or stolen, the Company in its discretion may
issue and deliver a new Compensation Warrant Certificate of like date and tenor as the one mutilated, lost, destroyed or stolen
in exchange for, and in place of, and upon cancellation of such mutilated Compensation Warrant Certificate, or in lieu of and
in substitution for such lost, destroyed or stolen Compensation Warrant Certificate, and the Compensation Warrants represented
by such substituted Compensation Warrant Certificate will be entitled to the benefit hereof and rank equally in accordance with
its terms with all other Compensation Warrants of the same issue. The Company may charge a reasonable fee for the issuance and
delivery of a new Compensation Warrant Certificate.

 

2.2
The applicant for the issue of a new Compensation Warrant Certificate pursuant hereto will bear the cost of the issue thereof
and in the case of loss, destruction or theft furnish to the Company such evidence of ownership, and of loss, destruction or theft
of the Compensation Warrant Certificate so lost, destroyed or stolen as will be satisfactory to the Company in its discretion;
and such applicant may also be required to furnish indemnity in amount and form satisfactory to the Company in its discretion
and will pay the reasonable charges of the Company in connection therewith.

 

Holder
not a Shareholder

 

2.3
The holding of a Compensation Warrant will not constitute the Holder a shareholder of the Company, nor entitle the Holder to any
right or interest in respect thereof, except as expressly provided in the Compensation Warrant Certificate.

 

Securities
Law Exemption

 

2.4
The Holder acknowledges and agrees that the Compensation Warrants and any Units issued pursuant to the exercise of any Compensation
Warrants have been or will be issued only on a “private placement” basis and that the Company has no obligation to,
and does not intend to, file any prospectus or registration statement in any jurisdiction in order to qualify any of such Compensation
Warrants and/or Units for resale.

 

Part
3

 

OWNERSHIP
AND TRANSFER OF compensation Warrant

 

Exchange
of Compensation Warrants

 

3.1
A Compensation Warrant Certificate in any authorized denomination, upon compliance with the reasonable requirements of the Company,
may be exchanged for a Compensation Warrant Certificate(s) in any other authorized denomination of the same issue entitling the
Holder to purchase an equal aggregate number of Units at the same Exercise Price and on the same terms as the Compensation Warrant
Certificate so exchanged.

 

3.2
The Compensation Warrants may be exchanged only with the Company. Any Compensation Warrants tendered for exchange will be surrendered
to the Company and cancelled.

 

Limitations
on Transfer

 

3.3
The Compensation Warrants are non-transferable, except by operation of law.

 

    	 

    	-4-

    

 

Charges
for Exchange

 

3.4
On exchange of Compensation Warrants, the Company, except as otherwise herein provided, may charge a reasonable fee for each new
Compensation Warrant Certificate issued, and payment of any transfer taxes or governmental or other charges required to be paid
will be made by the party requesting such exchange.

 

Ownership
of Compensation Warrants

 

3.5
The Company may deem and treat the Holder of a Compensation Warrant as the absolute owner of such Compensation Warrant for all
purposes and will not be affected by any notice or knowledge to the contrary.

 

Notice
to Holder

 

3.6
Unless herein otherwise expressly provided, any notice to be given hereunder to a Holder will be deemed to be validly given, if
mailed to the address of the Holder as set out on the Compensation Warrant Certificate. Any notice mailed to the address of the
Holder as set out on the Compensation Warrant Certificate will be deemed to have been received five days from the date of mailing
to the Holder or any market intermediary then holding the Compensation Warrants of the Holder in any trust account.

 

Part
4

 

EXERCISE
OF Compensation WarrantS

 

Method
of Exercise of Compensation Warrants

 

4.1
The right to purchase Units conferred by a Compensation Warrant may be exercised by the Holder surrendering the Compensation Warrant
Certificate, together with a duly completed and executed Warrant Exercise Form and a certified cheque or bank draft payable to,
or to the order of Company at the address as set out on the Compensation Warrant Certificate, for the purchase price applicable
at the time of surrender in respect of the Units subscribed for in lawful money of Canada to the Company at the address as set
out on the Warrant Exercise Form.

 

4.2
In the event that this Compensation Warrant is exercised at any time after the conversion of the Preferred Shares into Common
Shares in accordance with the terms and conditions Preferred Shares, the Units will be comprised of one Common Share and one Common
Share Warrant, each subject to the adjustment provisions set forth herein, and any references to issuances of Preferred Shares
will be deemed to be a reference to the issuance of Common Shares.

 

Effect
of Exercise of Compensation Warrants

 

4.3
Upon surrender and payment as aforesaid, the Units so subscribed for will be deemed to have been issued, and the Holder will be
deemed to have become the holder of such Units on the date of such surrender and payment, and such Units will be issued at the
Exercise Price as may be adjusted in the events and in the manner described herein.

 

4.4
Within 5 business days after surrender and payment as aforesaid, the Company will forthwith cause to be delivered to the person
in whose name the Preferred Shares and Common Share Warrants comprising the Units are directed to be registered as specified in
such Warrant Exercise Form, or if no such direction is given, the Holder, a certificate for the appropriate number of Preferred
Shares and Common Share Warrants comprising the Units not exceeding those which the Holder is entitled to purchase pursuant to
the Compensation Warrant Certificate surrendered.

 

    	 

    	-5-

    

 

Subscription
for Less than Entitlement

 

4.5
A Holder may purchase a number of Units less than the number which the Holder is entitled to purchase pursuant to the surrendered
Compensation Warrant Certificate. In the event of any purchase of a number of Units less than the number which can be purchased
pursuant to a Compensation Warrant Certificate, the Holder, upon exercise thereof, will, in addition to certificates representing
the Preferred Shares and Common Share Warrants comprising the Units issued on such exercise, and be entitled to receive a new
Compensation Warrant Certificate in respect of the balance of the Units which the Holder was entitled to purchase pursuant to
the surrendered Compensation Warrant Certificate but which were not then purchased.

 

Compensation
Warrants for Fractions of Units

 

4.6
To the extent that a Holder is entitled to receive on the exercise or partial exercise thereof a fraction of a Unit, such right
may be exercised in respect of such fraction only in combination with another Compensation Warrant which in the aggregate will
entitle the Holder to receive a whole number of Units.

 

Expiration
of Compensation Warrants

 

4.7
After the Expiry Date, all rights under the Compensation Warrants will wholly cease and terminate, and the Compensation Warrants
will thereupon be void and of no effect.

 

Exercise
Price

 

4.8
The price per Unit which must be paid to exercise a Compensation Warrant is the Exercise Price, as may be adjusted in the events
and in the manner described herein.

 

Acceleration
of Expiry Date

 

4.9
In the event that the Common Shares trade for a minimum of $3.00 per Common Share for any 10 consecutive trading days at any time
prior to the Expiry Date, the Company may accelerate the Expiry Date for the Compensation Warrants as follows:

 

(a)
the Company will be entitled to give notice of acceleration (an “Acceleration Notice”) to the Holder in order
to accelerate the Expiry Date;

 

(b)
upon delivery of an Acceleration Notice to a Holder, the Expiry Date will be accelerated to 5:00pm on the date that is 30 calendar
days from the date of delivery of the Acceleration Notice to the Holder (the “Accelerated Expiry Date”);

 

(c)
the Holder will be entitled to exercise the Compensation Warrants up to the Accelerated Expiry Date; and

 

(d)
if the Holder does not exercise the Compensation Warrants by the Accelerated Expiry Date, the Compensation Warrant and the rights
provided under this Compensation Warrant Certificate will terminate.

 

    	 

    	-6-

    

 

Part
5

 

Adjustments

 

Adjustments

 

5.1
If and whenever the Preferred Shares or the Common Shares underlying the Common Share Warrants will be subdivided into a greater
or consolidated into a lesser number of Preferred Shares or Common Shares, as applicable, or in the event of any payment by the
Company of a stock dividend (other than a dividend paid in the ordinary course), or in the event that the Company conducts a rights
offering to its shareholders, the Exercise Price and/or the exercise price of the Common Share Warrants will be decreased or increased
proportionately, as the case may be. Upon any such subdivision, consolidation, payment of a stock dividend or rights offering,
the number of Preferred Shares and/or Common Shares underlying the Common Share Warrants deliverable upon the exercise of a Compensation
Warrant and the exercise price of the Compensation Warrant and/or the exercise price of the Common Share Warrant will be increased
or decreased proportionately, as the case may be.

 

5.2
In case of any reclassification of the capital of the Company, or in the case of the merger, reorganization or amalgamation of
the Company with, or into any other company (including, for greater certainty, any triangular merger or three-cornered amalgamation
to which the Company is party) or of the sale of substantially all of the property and assets of the Company to any other company
(in each case, a “Corporate Event”), each Compensation Warrant will, after such Corporate Event, confer the
right to purchase that number of Units or other securities or property of the Company or of the company resulting from such Corporate
Event, as the case may be, which the Holder would then hold if the Holder had exercised the Holder’s rights under the Compensation
Warrant before the Corporate Event; and in any such case, if necessary, appropriate adjustments will be made in the application
of the provisions set forth in this Part 5 with respect to the rights and interest thereafter of the Holders to the end that the
provisions set forth in this Part 5 will thereafter correspondingly be made applicable as nearly as may reasonably be in relation
to any Shares or other securities or property thereafter deliverable on the exercise of a Compensation Warrant.

 

5.3
In case of any Corporate Event which results in Compensation Warrants becoming exercisable for units, securities or other property
of a corporate entity other than the Company, such corporate entity may elect to deliver to the Holder a new warrant certificate
in the name of such corporate entity reflecting the terms of the Compensation Warrants, as adjusted pursuant to §5.2, and
upon receipt of such replacement warrant certificate this Compensation Warrant Certificate will be deemed cancelled.

 

5.4
The adjustments provided for in this Part 5 are cumulative.

 

Determination
of Adjustments

 

5.5
If any question will at any time arise with respect to any adjustments to be made under §5.1 and §5.2, such question
will be conclusively determined by the Company’s auditor, or, if the Company’s auditor declines to so act, any other
chartered accountant in Vancouver, British Columbia that the Company may designate (acting reasonably) and who will have access
to all appropriate records, and such determination will be binding upon the Company and the Holder.

 

Hold
Period

 

5.6
The Preferred Shares and Common Share Warrants comprising the Units received by the Holder upon the exercise of the Compensation
Warrants, and the Common Shares issuable upon exercise of the Common Share Warrants, may be subject to a hold period as determined
by the Securities Act (British Columbia) and/or other applicable securities laws.

 

    	 

    	-7-

    

 

Part
6

 

COVENANTS
BY THE COMPANY

 

Reservation
of Shares

 

6.1
The Company will reserve, and there will remain unissued out of its authorized capital, a sufficient number of Preferred Shares
and Common Shares to satisfy the rights of purchase provided for in all Compensation Warrants from time to time outstanding.

 

Part
7

 

MODIFICATION
OF TERMS, SUCCESSORS

 

Modification
of Terms and Conditions for Certain Purposes

 

7.1
From time to time the Company may, subject to the provisions of the Compensation Warrant Certificate, when so directed by the
Holders, modify the terms and conditions hereof, for any one or more or all of the following purposes:

 

(a)
adding to the provisions hereof such additional covenants and enforcement provisions as, in the opinion of counsel for the Company,
are necessary or advisable in the circumstances;

 

(b)
making such provisions not inconsistent herewith as may be necessary or desirable with respect to matters or questions arising
hereunder or for the purpose of obtaining a listing or quotation of Compensation Warrants on any stock exchange;

 

(c)
adding to or altering the provisions hereof in respect of the registration of Compensation Warrants making provision for the exchange
of Compensation Warrant Certificates of different denominations; and making any modification in the form of Compensation Warrant
Certificates which does not affect the substance thereof;

 

(d)
for any other purpose not inconsistent with the terms hereof, including the correction or rectification of any ambiguities, defective
provisions, errors or omissions herein; and

 

(e)
to evidence any succession of any corporation and the assumption by any successor of the covenants of the Company herein and in
the Compensation Warrants contained as provided hereafter in this Part 7.

 

Company
may Amalgamate on Certain Terms

 

7.2
Nothing herein contained will prevent any amalgamation or merger of the Company with or into any other company, or the sale of
the property or assets of the Company to any company lawfully entitled to acquire the same; provided however that the company
formed by such merger or amalgamation or which acquires by conveyance or transfer all or substantially all the properties and
assets of the Company will be a company organized and existing under the laws of Canada or of the United States of America or
any Province, State, District or Territory thereof, which will, simultaneously with such amalgamation, merger, conveyance or transfer,
assume the due and punctual performance and observance of all the covenants and conditions hereof to be performed or observed
by the Company and will succeed to and be substituted for the Company, and such changes in phraseology and form (but not in substance)
may be made in the Compensation Warrant Certificate as may be appropriate in view of such amalgamation, merger or transfer.

 

Additional
Financings

 

7.3
Nothing herein contained will prevent the Company from issuing any other securities or rights with respect thereto during the
period within which a Compensation Warrant is exercisable, upon such terms as the Company may deem appropriate.

 

[End
of Schedule “A”]

 

    	 

    	 

    

 

APPENDIX
“A”

 

INSTRUCTIONS
TO HOLDERS

 

TO
EXERCISE:

 

To
exercise Compensation Warrants, the Holder must complete, sign and deliver the Warrant Exercise Form, attached as Appendix “B”
and deliver the Compensation Warrant Certificate(s) to the Company, indicating the number of Units to be acquired.

 

GENERAL:

 

If
forwarding any documents by mail, registered mail must be employed.

 

If
the Warrant Exercise Form is signed by a trustee, executor, administrator, curator, guardian, attorney, officer of a corporation
or any person acting in a fiduciary or representative capacity, the Compensation Warrant Certificate must also be accompanied
by evidence of authority to sign satisfactory to the Company.

 

The
address of the Company is:

 

Canivate
Growing Systems Ltd.

Suite
500, 1112 West Pender Street

Vancouver,
BC V6G 2S1

 

Attention:
Chief Financial Officer

 

[End
of Appendix “A”]

 

    	 

    	 

    

 

APPENDIX
“B”

 

COMPENSATION
WARRANT EXERCISE FORM

 

	TO:	Canivate
    Growing Systems Ltd.	 
	 	Suite
    500, 1112 West Pender Street	 
	 	Vancouver,
    BC V6G 2S1	 
	 	 	 
	 	Attention:
    Chief Financial Officer 	 

  

The
undersigned Holder of the within Compensation Warrants hereby subscribes for ____________ units (the “Units”)
of Canivate Growing Systems Ltd. (the “Company”) pursuant to the within Compensation Warrants on the terms
and price specified in the Compensation Warrants. Each Unit will be comprised of: (i) one (1) Series A preferred share (a “Preferred
Share”) and (ii) one (1) common share purchase warrant (a “Common Share Warrant”) of the Company,
subject to adjustment as provided in the Compensation Warrant Certificate. This subscription is accompanied by a certified cheque
or bank draft payable to or to the order of the Company for the whole amount of the purchase price of the Units.

 

The
undersigned hereby directs that the Preferred Shares and Common Share Warrants comprising the Units be registered as follows:

 

	NAME(S)
    IN FULL	 	ADDRESS(ES)	 	NUMBER
    OF UNITS
	 	 	 	 	 

 

If
the Units are issued prior to completion of the applicable seasoning period under securities legislation, the certificate(s) representing
the Preferred Shares and Common Share Warrants comprising the Units will bear the following legend:

 

UNLESS
PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY MUST NOT TRADE THE SECURITY BEFORE THE DATE THAT IS 4 MONTHS
AND A DAY AFTER THE LATER OF (I) MAY 2, 2019, AND (II) THE DATE THE CORPORATION
BECAME A REPORTING ISSUER IN ANY PROVINCE OR TERRITORY OF CANADA.

 

	DATED this _________ day of _______________, 20_____.
	 	 	 
	In
    the presence of:	 	 
	 	 	 
	 	 	 
	Signature
    of Witness	 	Signature
    of Holder
	 	 	 
	 	 	 
	Witness’s
    Name	 	Name
    and Title of Authorized Signatory for the Holder

 

	Please print below your name and address in full.
	 	 	 
	Legal
    Name 	 	 
	 	 	 
	Address	 	 

 

    	 

    	-2-

    

 

INSTRUCTIONS
FOR SUBSCRIPTION

 

The
signature to the subscription must correspond in every particular with the name written upon the face of the Compensation Warrant
Certificate without alteration. If the certificates representing the Preferred Shares and Common Share Warrants comprising the
Units to be issued upon exercise of the Compensation Warrants differs from the registration of the Compensation Warrant Certificates,
the signature of the registered holder must be guaranteed by an authorized officer of a Canadian chartered bank, or of a major
Canadian trust company, or by a medallion signature guarantee from a member recognized under the Signature Medallion Guarantee
Program, or from a similar entity in the United States, if this transfer is executed in the United States, or in accordance with
industry standards.

 

In
the case of persons signing by agent or attorney or by personal representative(s), the authority of such agent, attorney or representative(s)
to sign must be proven to the satisfaction of the Company.

 

If
the Compensation Warrant Certificate and the form of subscription are being forwarded by mail, registered mail must be employed.

 

[End
of Appendix “B”]

 

    	 

    	-3-

    

 

SCHEDULE
“B”

 

FORM
OF COMMON SHARE WARRANT CERTIFICATE

 

[attached]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00318-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00318-of-00352.parquet"}]]